Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2005

Cramer SF. I enjoyed the article about reserve cells. Hum Pathol. 2005;36(8):932-3; author reply 934-5.

Patterson CC, Ross P, Pope-Harman AL, Knight DA, Magro CM. Alpha-1 anti-trypsin deficiency and Henoch-Schönlein purpura associated with anti-neutrophil cytoplasmic and anti-endothelial cell antibodies of immunoglobulin-A isotype. J Cutan Pathol. 2005;32(4):300-6.

Halaas JL, Moskowitz CH, Horwitz S, Portlock C, Noy A, Straus D, et al. R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy. Leuk Lymphoma. 2005;46(4):541-7.

English CM, Maluf NK, Tripet B, Churchill ME, Tyler JK. ASF1 binds to a heterodimer of histones H3 and H4: a two-step mechanism for the assembly of the H3-H4 heterotetramer on DNA. Biochemistry. 2005;44(42):13673-82.

Han WK, Alinani A, Wu C-, Michaelson D, Loda M, McGovern FJ, et al. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. J Am Soc Nephrol. 2005;16(4):1126-34.

Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115(5):1343-51.

Sachdeva M, Frambach GE, A Crowson N, Deng AC, Mihm MC, Magro CM. De novo intraepidermal epithelioid melanocytic dysplasia as a marker of the atypical mole phenotype -- a clinical and pathological study of 75 patients. J Cutan Pathol. 2005;32(9):622-8.

Magro CM, Frambach GE, A Crowson N. Chondrodermatitis nodularis helicis as a marker of internal disease [corrected] associated with microvascular injury. J Cutan Pathol. 2005;32(5):329-33.

Lechpammer M, Xu X, F Ellis H, Bhattacharaya N, Shapiro GI, Loda M. Flavopiridol reduces malignant transformation of the esophageal mucosa in p27 knockout mice. Oncogene. 2005;24(10):1683-8.

Garcia-Cao I, Duran A, Collado M, Carrascosa MJ, Martín-Caballero J, Flores JM, et al. Tumour-suppression activity of the proapoptotic regulator Par4. EMBO Rep. 2005;6(6):577-83.